ABSTRACT
BACKGROUND: The COVID-19 pandemic has had a negative effect on surgical education in Latin America, decreasing residents' surgical training and supervised clinical practice. AIMS: This study aimed to identify strategies that have been proposed or implemented to adapt surgical training and supervised clinical practice to COVID-19-related limitations in Latin America. METHOD: A literature review was performed between April and May 2021, divided into two searches. The first one sought to identify adaptation strategies in Latin America for surgical training and supervised clinical practice. The second one was carried out as a complement to identify methodologies proposed in the rest of the world. RESULTS: In the first search, 16 of 715 articles were selected. In the second one, 41 of 1,637 articles were selected. Adaptive strategies proposed in Latin America focused on videoconferencing and simulation. In the rest of the world, remote critical analysis of recorded/live surgeries, intrasurgical tele-mentoring, and surgery recording with postoperative feedback were suggested. CONCLUSIONS: Multiple adaptation strategies for surgical education during the COVID-19 pandemic have been proposed in Latin America and the rest of the world. There is an opportunity to implement new strategies in the long term for surgical training and supervised clinical practice, although more prospective studies are required to generate evidence-based recommendations.
Subject(s)
COVID-19 , Humans , Latin America , Pandemics , Prospective StudiesABSTRACT
SARS-CoV-2 is a new virus causing an infection and illness referred to as COVID-19. As of July 7th of 2020, this virus has been associated worldwide with over 12 million of infections and more than 550,000 deaths. Transmission rate of SARS-CoV-2 in the population is high, and the origin of this coronavirus appears to be related to some species of the bat. However, scientific information related to the pathogenesis, and immune response to COVID-19 changes rapidly, which is why the aim of this work is to provide recent information related to an exacerbated inflammatory immune response which causes multiorgan failure and patient death. The timely identification of infected individuals will be key to stop the spread of infection and in severe cases to establish optimal strategies to reduce the risk of death in critically ill patients. In this review, we have considered the latest findings collected from the clinical studies, diagnostic tests, and treatment for COVID-19. Information presented here will help to the better understanding of this disease.
El SARS-CoV-2 es un nuevo virus que causa la enfermedad denominada COVID-19. Este virus ha generado hasta el 7 de julio de 2020 12 millones de contagios y más de 550 000 muertes en todo el mundo. Se sabe que la tasa de transmisión es muy alta y su origen está relacionado con una especie del murciélago. Sin embargo, la información científica relacionada con la COVID-19 cambia rápidamente, por lo que este trabajo tiene como objetivo aportar información reciente y relacionada con el desarrollo de la respuesta inflamatoria exacerbada, que con frecuencia causa falla orgánica múltiple y muerte del paciente. La rápida identificación de los individuos infectados es clave para detener la propagación de esta enfermedad y en los casos más graves establecer estrategias que permitan la reducción de la infección y del riesgo de muerte. En esta revisión, hemos considerado los últimos hallazgos recopilados de los estudios clínicos, pruebas diagnósticas y de tratamiento para COVID-19. La información presentada en este trabajo contribuirá al entendimiento de esta enfermedad.
ABSTRACT
Not available.
Subject(s)
COVID-19 Serological Testing/methods , COVID-19/diagnosis , Pandemics , SARS-CoV-2/immunology , COVID-19/blood , COVID-19/epidemiology , Confidence Intervals , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Latin America/epidemiology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
It has been suggested that high altitude can reduce the infectivity and case fatality rate of COVID-19. We investigated the relationship between altitude and the COVID-19 pandemic in Colombia. Epidemiological data included the number of positive cases, deaths, and the case fatality rate of COVID-19. In particular, we analyzed data from 70 cities with altitudes between 1 and 3,180 m. Correlations and linear regression models adjusted to population density were performed to examine the relationship and contribution of altitude to epidemiological variables. The case fatality rate was negatively correlated with the altitude of the cities. The incidence of cases and deaths from COVID-19 had an apparent correlation with altitude; however, these variables were better explained by population density. In general, these findings suggest that living at high altitude can reduce the impact of COVID-19, especially the case fatality rate.